Search
for
Sort by
Research 241–270 of 1000+
- Dermatologic Reactions to Targeted Therapy
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Alopecia areata
- Sorafenib-induced Facial Acneiform Eruption
- Roles of tumor suppressors in regulating tumor-associated inflammation
- The concealed side of caspases: beyond a killer of cells
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Flexural Agminated Eruptive Nevi in Langerhans Cell Histiocytosis
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series